Published in
American Medical Association, JAMA Oncology, 3(4), p. 302
DOI: 10.1001/jamaoncol.2017.4612
Links
Tools
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial
Journal article published in 2018 by
Luca Gianni 
,
Mauro Mansutti,
Antonio Anton,
Lourdes Calvo ,
Giancarlo Bisagni,
Begoña Bermejo,
Vladimir Semiglazov,
Marc Thill,
Jose Ignacio Chacon,
Arlene Chan,
Serafin Morales ,
Isabel Alvarez,
Arrate Plazaola,
Milvia Zambetti,
Andrew D. Redfern
and other authors.
,
Mauro Mansutti,
Antonio Anton,
Lourdes Calvo ,
Giancarlo Bisagni,
Begoña Bermejo,
Vladimir Semiglazov,
Marc Thill,
Jose Ignacio Chacon,
Arlene Chan,
Serafin Morales ,
Isabel Alvarez,
Arrate Plazaola,
Milvia Zambetti,
Andrew D. Redfern
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 